Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity

Obesity is associated with low-grade chronic inflammation. Here the authors show that the activation of anti-inflammatory M2a-subtype macrophages requires the IL4/Irs2/Akt pathway. Due to decreased Irs2 expression this pathway is impaired in obese mice thus leading to a defect in M2a activation.

Guardado en:
Detalles Bibliográficos
Autores principales: Tetsuya Kubota, Mariko Inoue, Naoto Kubota, Iseki Takamoto, Tomoka Mineyama, Kaito Iwayama, Kumpei Tokuyama, Masao Moroi, Kohjiro Ueki, Toshimasa Yamauchi, Takashi Kadowaki
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/5c16b774daf24a59904c928896c9f12b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5c16b774daf24a59904c928896c9f12b
record_format dspace
spelling oai:doaj.org-article:5c16b774daf24a59904c928896c9f12b2021-12-02T17:32:46ZDownregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity10.1038/s41467-018-07358-92041-1723https://doaj.org/article/5c16b774daf24a59904c928896c9f12b2018-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-07358-9https://doaj.org/toc/2041-1723Obesity is associated with low-grade chronic inflammation. Here the authors show that the activation of anti-inflammatory M2a-subtype macrophages requires the IL4/Irs2/Akt pathway. Due to decreased Irs2 expression this pathway is impaired in obese mice thus leading to a defect in M2a activation.Tetsuya KubotaMariko InoueNaoto KubotaIseki TakamotoTomoka MineyamaKaito IwayamaKumpei TokuyamaMasao MoroiKohjiro UekiToshimasa YamauchiTakashi KadowakiNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-15 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Tetsuya Kubota
Mariko Inoue
Naoto Kubota
Iseki Takamoto
Tomoka Mineyama
Kaito Iwayama
Kumpei Tokuyama
Masao Moroi
Kohjiro Ueki
Toshimasa Yamauchi
Takashi Kadowaki
Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity
description Obesity is associated with low-grade chronic inflammation. Here the authors show that the activation of anti-inflammatory M2a-subtype macrophages requires the IL4/Irs2/Akt pathway. Due to decreased Irs2 expression this pathway is impaired in obese mice thus leading to a defect in M2a activation.
format article
author Tetsuya Kubota
Mariko Inoue
Naoto Kubota
Iseki Takamoto
Tomoka Mineyama
Kaito Iwayama
Kumpei Tokuyama
Masao Moroi
Kohjiro Ueki
Toshimasa Yamauchi
Takashi Kadowaki
author_facet Tetsuya Kubota
Mariko Inoue
Naoto Kubota
Iseki Takamoto
Tomoka Mineyama
Kaito Iwayama
Kumpei Tokuyama
Masao Moroi
Kohjiro Ueki
Toshimasa Yamauchi
Takashi Kadowaki
author_sort Tetsuya Kubota
title Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity
title_short Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity
title_full Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity
title_fullStr Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity
title_full_unstemmed Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity
title_sort downregulation of macrophage irs2 by hyperinsulinemia impairs il-4-indeuced m2a-subtype macrophage activation in obesity
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/5c16b774daf24a59904c928896c9f12b
work_keys_str_mv AT tetsuyakubota downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT marikoinoue downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT naotokubota downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT isekitakamoto downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT tomokamineyama downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT kaitoiwayama downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT kumpeitokuyama downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT masaomoroi downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT kohjiroueki downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT toshimasayamauchi downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
AT takashikadowaki downregulationofmacrophageirs2byhyperinsulinemiaimpairsil4indeucedm2asubtypemacrophageactivationinobesity
_version_ 1718380187261861888